John Berman
Chief Administrative Officer at LARIMAR THERAPEUTICS, INC.
Profile
John Berman is currently the Vice President-Finance & Operations at Chondrial Therapeutics, Inc. He is also the Treasurer & Vice President-Finance & Operations at Chondrial Therapeutics Holdings LLC.
Additionally, he holds the position of Vice President-Finance & Administration at Larimar Therapeutics, Inc. Previously, he worked as the Senior Director-Corporate Alliance Management at Teva Pharmaceuticals USA, Inc. Mr. Berman completed his undergraduate degree at the University of Pennsylvania and holds an MBA from The Wharton School of the University of Pennsylvania.
John Berman active positions
| Companies | Position | Start |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Chief Administrative Officer | - |
Chondrial Therapeutics, Inc.
 Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chondrial Therapeutics, Inc. operates as a biotechnology company which focuses on the treatment of rare mitochondrial diseases. Its compound is CTI-1601, which the company is developing as a potential treatment for Friedreich’s Ataxia. The company was founded by Steven R. Plump and Mark R. Payne and is headquartered in Bala Cynwyd, PA. | Director of Finance/CFO | 2016-12-31 |
Chondrial Therapeutics Holdings LLC
 Chondrial Therapeutics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Chondrial Therapeutics Holdings LLC engages in operation of a biotechnology firm. The company was founded in 2016 and is headquartered in Bala Cynwyd, PA. | Director of Finance/CFO | - |
Former positions of John Berman
| Companies | Position | End |
|---|---|---|
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | - |
Training of John Berman
| University of Pennsylvania | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LARIMAR THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Chondrial Therapeutics, Inc.
Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chondrial Therapeutics, Inc. operates as a biotechnology company which focuses on the treatment of rare mitochondrial diseases. Its compound is CTI-1601, which the company is developing as a potential treatment for Friedreich’s Ataxia. The company was founded by Steven R. Plump and Mark R. Payne and is headquartered in Bala Cynwyd, PA. | Health Technology |
Chondrial Therapeutics Holdings LLC
Chondrial Therapeutics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Chondrial Therapeutics Holdings LLC engages in operation of a biotechnology firm. The company was founded in 2016 and is headquartered in Bala Cynwyd, PA. | Commercial Services |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
- Stock Market
- Insiders
- John Berman
